Cadila Of India Sued By Shire Of Ireland Over U.S. Bowel Drug Patent
This article was originally published in PharmAsia News
Executive Summary
India's Cadila Healthcare has been sued in a U.S. court by Shire, an Ireland-based drug maker, to block a generic version of the Shire medicine Lialda (mesalamine) for treating bowel disorder